# iHuman Inc.: financial statements, quarterly

IH · NYSE · CIK 1814423 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ih.md) · [Financials](/companies/ih/financials.md) · [Filings](/companies/ih/filings.md) · [Insiders](/companies/ih/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ih/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [132](/filings/0001104659-21-056545.md) | [134](/filings/0001104659-22-053581.md) | [152](/filings/0001104659-23-049598.md) | [171](/filings/0001104659-24-051629.md) | [154](/filings/0001410578-25-000944.md) | [165](/filings/0001104659-26-048541.md) |
| Current assets | $m | [157](/filings/0001104659-21-056545.md) | [159](/filings/0001104659-22-053581.md) | [182](/filings/0001104659-23-049598.md) | [195](/filings/0001104659-24-051629.md) | [183](/filings/0001410578-25-000944.md) | [186](/filings/0001104659-26-048541.md) |
| Total assets | $m | [160](/filings/0001104659-21-056545.md) | [173](/filings/0001104659-22-053581.md) | [193](/filings/0001104659-23-049598.md) | [204](/filings/0001104659-24-051629.md) | [194](/filings/0001410578-25-000944.md) | [196](/filings/0001104659-26-048541.md) |
| Current liabilities | $m | [61.2](/filings/0001104659-21-056545.md) | [75.8](/filings/0001104659-22-053581.md) | [81.3](/filings/0001104659-23-049598.md) | [69.1](/filings/0001104659-24-051629.md) | [61.3](/filings/0001410578-25-000944.md) | [52.0](/filings/0001104659-26-048541.md) |
| Total liabilities | $m | [62.0](/filings/0001104659-21-056545.md) | [77.3](/filings/0001104659-22-053581.md) | [81.8](/filings/0001104659-23-049598.md) | [69.4](/filings/0001104659-24-051629.md) | [62.9](/filings/0001410578-25-000944.md) | [53.4](/filings/0001104659-26-048541.md) |
| Shareholders' equity | $m | [98.5](/filings/0001104659-21-056545.md) | [95.5](/filings/0001104659-22-053581.md) | [112](/filings/0001104659-23-049598.md) | [135](/filings/0001104659-24-051629.md) | [132](/filings/0001410578-25-000944.md) | [142](/filings/0001104659-26-048541.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.